NCT00297674View on ClinicalTrials.gov

Intravenous Clarithromycin in Septic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2005

Conditions
SepsisVentilator Associated Pneumonia
Interventions
DRUG

Intravenous Clarithromycin

Trial Locations (3)

106 72

1st Department of Critical Care, Evangelismos General Hospital, Athens

124 64

2nd Department of Critical Care, ATTIKON University Hospital, Athens

4th Department of Internal Medicine, ATTIKON University Hospital, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT00297674 - Intravenous Clarithromycin in Septic Syndrome | Biotech Hunter | Biotech Hunter